Investment Watch Autumn 2025 Outlook
Investment Watch is a quarterly publication for insights in equity and economic strategy. US President Donald Trump’s “liberation day” tariffs have rattled global markets. Since the pronouncement, most global indices have been down by over 10%.
Investment Watch is a quarterly publication produced by Morgans that delves into key insights for equity and economic strategy.
This publication covers
Economics - Tariffs and uncertainty: Charting a course in global trade
Asset Allocation - Look beyond the usual places for alpha
Equity Strategy - Broadening our portfolio exposure
Fixed Interest - A step forward for corporate bond reform
Banks - Post results season volatility
Industrials - Volatility creates opportunities
Resources and Energy - Trade war blunts near term sentiment
Technology - Opportunities emerging
Consumer discretionary - Encouraging medium-term signs
Telco - A cautious eye on competitive intensity
Travel - Demand trends still solid
Property - An improving Cycle
US President Donald Trump’s “liberation day” tariffs have rattled global markets. Since the pronouncement, most global indices have been down by over 10%. The scope and magnitude of the tariffs are more severe than we, and the market, expected. These are emotional times for investors, but for those with a long-term perspective, we believe short-term market volatility is a distraction that is better off ignored.
While the market could be in for a bumpy ride over the next few months, patience, a well-thought-out strategy, and the ability to look through market turbulence are key to unlocking performance during such unusual times. This quarter, we cover the economic implications of the announced tariffs and how this shapes our asset allocation decisions. We also provide an outlook for the key sectors of the Australian market and where we see the best tactical opportunities.
Morgans clients receive exclusive insights such as access to our latest Investment Watch publication. Contact us today to begin your journey with Morgans.

- As attention turns to the February first half reporting season, earnings estimates continue to defy expectations of an imminent slowdown. However, fears that they will materially decelerate in 2H23 will temper sentiment when anticipated headwinds from rising interest rates hits home.
- Quantity and quality of earnings will come into focus as the macro takes a back seat to company fundamentals. Key themes to watch include FY23 earnings trends, cyclical signposts (consumer demand, industrial margins), China restart short selling and positioning in resources.
- Morgans analysts preview the results for 145 stocks under coverage that report in February and call out likely surprise and disappoint candidates from page 14.
- Key tactical trades (page 3) include Qantas (ASX:QAN), Megaport (ASX:MP1), Lovisa (ASX:LOV), Coles (ASX:COL) and HomeCo Daily Needs REIT (ASX:HDN).
No imminent slowdown
As attention turns to the February first half reporting season, earnings estimates continue to defy expectations of an imminent slowdown. ASX 200 earnings remain resilient despite deep cuts to estimates in other developed markets.
We point to the lack of guidance, frequency of trading updates and less acute inflation as reasons why forecasts have held up against the negative sentiment.
Headline estimates point to ASX Industrials growing 5.5% EPS in FY23 before tracking sideways in FY24-25. While growth looks subdued, corporate performance divergence will provide investors with opportunities. The broad valuation de-rating in 2022 will also give some further shelter.
With renewed focus on fundamentals, identifying companies that are less prone to earnings erosion will be key. These include companies that have a growing earnings profile, strong cash flow profiles and are trading at reasonable valuations.
Our preferred exposures include Qantas (ASX:QAN), Telstra Group (ASX:TLS), QBE Insurance Group (ASX:QBE), Treasury Wine Estate (ASX:TWE), and Corporate Travel Management (ASX:CTD).
Consumer and commodities – playing the cycle
The long-anticipated consumer slowdown so far has been more gentle than the market feared. We expect 1H retail results overall to be reasonable, but investors will be ever-cautious on the 12-month outlook.
However, we don’t see a ‘cliff’s edge’ for retail with the pace of decline potentially less pronounced than analysts are forecasting. The current balance of market expectations supports price strength in the more resilient retailers, especially those capable of growing market share (JBH, BLX, and UNI).
Dramatically improved sentiment – fueled by China re-opening – has arguably pushed the resources sector slightly ahead of fundamentals. While the medium-term outlook is compelling, we expect a bumpy ride in 2023 and prefer to stick with key producers South32 (ASX:S32), Mineral Resources (ASX:MIN), Santos (ASX:STO), and Karoon Energy (ASX:KAR).
Volatility bound – decoding the short interest signals
As the ASX 200 closes in on its 2022 high, short interest has been accumulating. We think illiquidity and uncertain trading conditions have brought short positions sharply into focus.
We’ve argued that earnings will attract greater focus this season as macro concerns affecting equities have eased in recent weeks.
We think conditions are ripe for volatility in and around the results with average days-to-cover increasing and significant crowding in individual stocks.

Morgans clients receive access to detailed market analysis and insights, provided by our award-winning research team. Begin your journey with Morgans today to view the exclusive coverage.

Your Wealth is a half-yearly publication produced by Morgans that delves into key insights for Wealth Management. This latest publication will cover;
- Maximise your retirement savings with super splitting strategies
- Staying the course while Central Banks tighten
- Spotlighting the new income thresholds for the Commonwealth Seniors Health Card
- The basics of account-based pensions
- How to wind up your self-managed super fund
- Big Dry Friday 2022: 1.3 million reasons to say thank you
Morgans clients receive exclusive insights such as access to our latest Your Wealth publication. Contact us today to begin your journey with Morgans.
Feature Article | Splitting is still significant
The strategy of splitting superannuation contributions to your spouse still provides an opportunity for couples to maximise their retirement savings, particularly with the introduction of total super balance and transfer balance cap rules.
Overview of Contribution Splitting
The superannuation contribution splitting rules allows a person to split up to 85% of concessional contributions with their spouse. This includes carry forward concessional contributions. Non-concessional contributions cannot be split. Superannuation contribution splitting allows a couple to build two separate superannuation accounts even if one spouse is on a low income or not working.
The splitting operates under an “annual split” model: that is at the end of the financial year a super fund member will be able to nominate a percentage of concessional contributions made in that financial year to be split with their spouse. The amount to be split will be treated as a “rollover” to the receiving spouse; hence funds will not be counted against any contribution caps for that spouse. The concessional contributions that can be split can also include unused carry forward contributions, where applicable.
To read the full coverage from the latest Your Wealth, begin your journey with Morgans today.

Investment Watch is a quarterly publication produced by Morgans that delves into key insights for equity and economic strategy. This latest publication will cover;
- Asset allocation – Positioning for a cyclical slowdown/mild recession
- Economic strategy – US economic growth to slow
- Equity strategy – Moving from defensives
- Updated Morgans Best Ideas
- … and much more
Morgans clients receive exclusive insights such as access to our latest Investment Watch publication. Contact us today to begin your journey with Morgans.
Feature Article | 2024 Outlook
A rapidly evolving investment landscape and a year of likely political uncertainty make forecasting difficult in 2024. We outline three possible scenarios:
- Economic soft landing involves a modest deceleration below trend in major economies, without significant shocks disrupting markets. The decision to maintain higher interest rates will bring inflation near central banks’ target range. This would enable a shift towards reducing interest rates, alleviating the strain on households and companies.
- A cyclical slowdown/mild recession resilience driven by fiscally supported consumers and companies has been the biggest surprise of 2023, but barring something extraordinary, next year could see the global economy finally turn lower. Inflation would be sticky for a period before returning to target, with interest rates staying higher for longer periods, resulting in bouts of asset price volatility.
- Economic hard landing/balance sheet recession will be defined by a sharp downturn in the global economy. A sharp acceleration in corporate defaults would significantly reduce corporate and consumer spending. Central banks would respond by cutting interest rates as growth and inflation fall away.
Equity strategy - Moving on from defensives
Our Asset Allocation update discusses three possible economic scenarios in 2024 and their investment implications in terms of portfolio asset allocation. Our base case scenario expects economic growth to contract in the first half of 2024 before returning to growth later in the year. Sticky inflation will keep interest rates higher for longer. Equities will likely remain range-bound until there is more certainty on the interest rate trajectory either peaking/falling.
Given Australia’s economic sensitivity to falling commodity prices, investors need to tread carefully over the next 3-6 months. As tailwinds from commodity prices fade, we think above-average earnings growth for the market will be harder to come by. Accordingly, we prefer a targeted portfolio approach, tilting toward what we believe are the best relative opportunities and the best risk/return profile e.g., small caps, quality cyclicals.
To read the full coverage from the latest Investment Watch, begin your journey with Morgans today.

Helloworld Travel Ltd (ASX:HLO) - Finally profitable
HLO's FY22 result beat expectations with the group returning to modest (EBITDA) profitability in the 4Q, despite the sale of the Corporate travel business. Cashflow and the balance sheet were also stronger than expected.
In a sign of confidence, HLO has rewarded shareholders with a 10cps final dividend. Add maintained.
Tyro Payments (ASX:TYR) - Pointing to a clear increase in operating leverage in FY23
TYR's FY22 Reported NPAT appeared below Bloomberg consensus (-A$29m versus -A$20m), but the result beat at EBITDA (A$10.5m versus A$8m consensus) while the mid-point of FY23 EBITDA guidance was ~+25% above consensus.
Add maintained. Our key result takeaway was the market had been waiting for TYR to give evidence of improving operating leverage, with FY23 EBITDA guidance of A$23m-29m (FY21 A$10.5m) particularly meeting that criteria.
Healius (ASX:HLS) - Pieces coming together- "a platform for growth"
FY22 underlying results were broadly in line with expectations, with double-digit revenue growth and ongoing cost outs driving leverage and robust cash flow. Not surprising, COVID testing underpinned the result, while Imaging and Day Hospitals went backwards on COVID-impacted elective surgery restrictions, lockdowns and increased costs.
We adjust our FY23-24 forecasts and roll forward valuation multiples. Add maintained.
Generation Dev Group (ASX:GDG) - A clean performance
In our view, this was a pretty clean result (without any obvious surprises), and it represented a relatively solid performance overall. Management also noted FY23 has seen a good start to the year for Investment Bond (IB) sales, albeit outlook commentary was pretty broad as per usual.
We continue to believe GDG is well positioned to execute a compound earnings growth story over time. Add maintained.
Morgans clients receive access to detailed market analysis and insights, provided by our award-winning research team. Begin your journey with Morgans today to view the exclusive coverage.

Wesfarmers Limited (ASX:WES)
WES's FY22 result was comfortably above expectations.
Management said retail trading conditions have remained robust through the first seven weeks of FY23. FY23-25F group underlying EBIT changes by between -1% and +3%. We maintain our Add rating. We continue to view WES as a core portfolio holding for long-term investors.
Ramsay Health Care (ASX:RHC)
FY22 results continue to be materially impacted by COVID and higher costs, with margins contracting to multi-year lows and profit falling by double-digits.
Despite lingering volatility and FY24 a "normal" trading year, it takes a back seat to KKR's now revised offer, which we believe is likely to get up in some form. We have adjusted our FY23-24 earnings, rolled forward our valuation multiples, and maintained a takeout premium. Move to Add.
Universal Store (ASX:UNI)
We believe UNI will deliver double-digit growth in sales and earnings in FY23 as an expanded store network plays into the resilience of demand for fashion apparel from a young customer cohort experiencing high levels of employment, higher wages and more and more opportunities to go out and socialise.
FY22 earnings were slightly better than expectations. We have increased our EPS estimates by 5% in FY23 and by 1% in FY26.
Peter Warren (ASX:PWR)
PWR's FY22 underlying NPAT of A$61.7m was up 18% on the pcp, beating expectations.
We are conscious of the operating deleverage impact when GM 'normalises', however more constrained supply is likely to persist for some time.
Industry consolidation will continue - we expect PWR to be a participant (primary growth driver), or even a potential target in time.
Jumbo Interactive (ASX:JIN)
FY22 was a year of solid growth in revenue and earnings for JIN. The business continued to diversify its earnings base, with SaaS now making up nearly half of group EBITDA.
We reiterate our Add rating. We expect JIN to continue to achieve steady growth in the years ahead through a combination of organic contract wins, M&A and diversification.
Monash IVF Group Ltd (ASX:MVF)
MVF posted a solid FY22 result which was in line with expectations and sustained the high level of stimulated cycles on the bumper FY21 year. Strong industry fundamentals remain in play, and MVF continues to gain market share and attract new fertility specialists.
We maintain our Add recommendation.
Morgans clients receive access to detailed market analysis and insights, provided by our award-winning research team. Begin your journey with Morgans today to view the exclusive coverage.
In the latest fiscal year, Wesfarmers Limited (ASX:WES) has impressively surpassed expectations, showcasing resilience amid challenging conditions.
FY22 Results Exceeding Expectations
Kmart Group, a standout performer, demonstrated a strong recovery in 2H22 following 1H22 lockdown impacts. Additionally, the FY22 Dividend Per Share (DPS) of 180cps exceeded forecasts and Bloomberg consensus. The Group's Return on Equity (ROE) surged by 330 basis points to an impressive 29.4%.
Challenges and Areas of Concern include a 120 basis points drop in the Group's EBIT margin to 9.3%. The Health division's EBIT, for the initial three months of ownership in FY22, reported at -$24 million. Furthermore, operating cash flow declined by 32% due to higher working capital, predominantly in inventory.
Retail trading conditions have remained robust, as assured by management through the first seven weeks of FY23. Projections for FY23-25F group underlying EBIT changes range between -1% and +3%.
Financial Performance
FY22 Result Overview: Underlying EBIT declined by 4% to $3,633 million, a 3% decrease in underlying NPAT to $2,352 million. Earnings in retail divisions were mixed, with Bunnings EBIT up slightly (+1%), while Kmart Group (-36%) and Officeworks (-14%) experienced weakness due to 1H22 lockdowns. The Industrials businesses had a good year, with WesCEF EBIT up 41% on the back of higher commodity prices, and Industrial & Safety EBIT rose 30%. EBIT for the newly created Health division (3 months) was -$24 million, including several one-off charges. Excluding these charges, Health EBIT was $12 million.
Bunnings and Kmart Performance
Bunnings Highlights
Bunnings FY22 EBIT rose by 1% on the back of 4.8% LFL sales growth. Although earnings were slightly below (-1%) forecasts, it was a commendable result given the strong growth over the past two years. EBIT margin fell 60 basis points to 13.1%, attributed to operational challenges related to COVID and ongoing supply chain disruptions. The change in mix from higher Trade activity also had a negative impact on margins. For FY23, Bunnings EBIT is forecasted to decrease by 3% to $2,248 million.
Kmart Group Resilience
Kmart Group FY22 EBIT decreased by 36% to $506 million, yet the result was 23% above forecasts. 2H22 performance (EBIT +12%) significantly improved from 1H22 performance (-58%), which was significantly affected by lockdowns. Trading conditions improved in 2H22 as restrictions eased. For FY23, Kmart Group EBIT is forecasted to jump by 67% to $843 million after cycling the lockdown impact in FY22.
Retail Conditions and Future Projections
Retail trading conditions have remained robust, particularly strong in Kmart Group, with sales significantly higher on both a one-year and two-year basis. Bunnings also continues to see positive sales growth on a one-year and two-year basis. Overall, the forecast for FY23 group underlying EBIT anticipates a 5% increase to $3,827 million.
Adjustments and Investment Outlook
Adjustments have been made to FY23F/24F/25F underlying EBIT by +3%/-1%/-1%. Underlying NPAT changes by -2%/-6%/-5%, reflecting a remodelling of net interest expense. The equally-blended (PE, SOTP, DCF) target price falls, maintaining the Add rating. Trading at 22.5x FY23F PE and a 3.8% yield, WES remains an attractive investment with a diversified group of retail and industrial brands, a solid balance sheet, and a strong leadership team poised to deliver long-term value for shareholders.